Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN14335124
ISRCTN14335124
Completed
未知

mHealth Biometrics for Type 2 Diabetes (MOTIVATE T2D)

iverpool John Moores University0 sites125 target enrollmentOctober 21, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsType 2 diabetesNutritional, Metabolic, EndocrineType 2 diabetes mellitus

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 diabetes
Sponsor
iverpool John Moores University
Enrollment
125
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34836904/ (added 29/11/2021)

Registry
who.int
Start Date
October 21, 2020
End Date
May 1, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
iverpool John Moores University

Eligibility Criteria

Inclusion Criteria

  • •1\. Clinical Diagnosis of T2D within the previous 5–24 months
  • •2\. Aged 40 \- 75 years
  • •3\. Treating diabetes with only Metformin or lifestyle modifications (diet and exercise)
  • •4\. For those prescribed Metformin: Stable dose for 3\-months or more

Exclusion Criteria

  • •1\. HbA1c \>10% (\>86mmol/mol)
  • •2\. Blood pressure \>160/100 mmHg
  • •3\. Prescription of oral antidiabetic drug other than Metformin
  • •4\. Prescription of Insulin
  • •5\. Unstable angina
  • •6\. Myocardial infarction within the previous 3 months
  • •7\. Transient ischemic attack (TIA) in the previous 6 months
  • •8\. Heart failure \>\= class 2
  • •9\. Inability to increase level of activity
  • •10\. Pregnancy or planning to become pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Support through mobile messaging and digital health technology for diabetesType 2 diabetes mellitusNutritional, Metabolic, Endocrine
ISRCTN13404264niversity of Oxford209
Unknown
Not Applicable
Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)Pre-diabetesDiabetes
NCT02838693Medicine2,300
Completed
Not Applicable
DECIDE-CV Using AIType 2 Diabetes
NCT05482958McGill University Health Centre/Research Institute of the McGill University Health Centre210
Unknown
Not Applicable
Mobile Health to Enhance Exercise in Type 2 DiabetesDiabetes Mellitus, Type 2TelemedicineMobile ApplicationsExercise Therapy
NCT04653532University of British Columbia120
Active, not recruiting
Not Applicable
Support through mobile messaging and digital health technology for diabetesType 2 diabetes mellitusNutritional, Metabolic, Endocrine
ISRCTN15952379niversity of Oxford1,039